Menu
Back to Journals » OncoTargets and Therapy » Volume 9
Short Report
Can we avoid dose escalation for intermediate-risk prostate cancer in the setting of short-course neoadjuvant androgen deprivation?
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,342 | Dovepress* | 4,971+ | 1,051 | 6,022 | |
| PubMed Central* | 371 | 110 | 481 | ||
| Totals | 5,342 | 1,161 | 6,503 | ||
|
*Since 17 March 2016 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 0 | 0 | 0 | 4 | 4 |
View citations on PubMed Central and Google Scholar